US Patent 7291725 Sos1 inhibitors
Patent 7291725 was granted and assigned to Chiron Corporation on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Birgit K. Jaitner0
Wendy J. Fantl0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+291 characters)
Article
Patent abstract
Inhibitors of human Sos1, including antisense oligonucleotides, methods, and compositions specific for human Sos1, are provided. Methods of using the compositions for modulating Sos1 expression and for regulating cell growth, particularly tumor cell growth, are also provided.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07291725 Sos1 inhibitors US Patent 7291725 Sos1 inhibitors
Infobox
Patent Number
072917250
Patent Number
72917250
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072917250
Date of Patent
November 6, 2007
0Patent Application Number
106091500
Date Filed
June 25, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07291725 Sos1 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07291725
Date of patent
November 6, 2007
Patent application number
10609150
Date Filed
June 25, 2003
Patent primary examiner
Find more entities like US Patent 7291725 Sos1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
